NCT06373744View on ClinicalTrials.gov

Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

597

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide , methotrexate , vinorelbine ,capecitabine

The drugs used in metronomic chemotherapy are cyclophosphamide (CTX), methotrexate (M), vinorelbine (VNR), and capecitabine

Trial Locations (1)

Unknown

Shusen Wang, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER